연구동향 분석

Prognostic Value of Serum Epstein–Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

Wan-Ru Zhang Yu-Yun Du Chun-Yan Guo Han-Xing Zhou Jie-Yi Lin Xiao-Han Meng Hao-Yuan Mo Dong-Hua Luo 년

논문상세정보
인용/피인용

' Prognostic Value of Serum Epstein–Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma' 의 참고문헌

  • The relationship between environmental factors and the profile of Epstein-Barr virus antibodies in the lytic and latent infection periods in healthy populations from endemic and nonendemic nasopharyngeal carcinoma areas in China
    He YQ [2018]
  • The enigmatic epidemiology of nasopharyngeal carcinoma
    Chang ET [2006]
  • The criteria to confirm the role of Epstein-Barr virus in nasopharyngeal carcinoma initiation
    Gu AD [2012]
  • Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma
    Ji MF [2007]
  • Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells
    Zebboudj A [2014]
  • Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma
    Sun P [2014]
  • Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma : experience of 370 consecutive cases
    Lin S [2010]
  • Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma
    Xu XF [2016]
  • Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells
    Hau PM [2015]
  • Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA
    Cai YL [2010]
  • Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
    Lin JC [2004]
  • Prospective studies on nasopharyngeal carcinoma in EpsteinBarr virus IgA/VCA antibody-positive persons in Wuzhou City, China
    Zeng Y [1985]
  • Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA
    Yao JJ [2017]
  • Prognostic value of plasma Epstein-Barr virus DNA for local and regionally advanced nasopharyngeal carcinoma treated with cisplatin-based concurrent chemoradiotherapy in intensity-modulated radiotherapy era
    Chen WH [2016]
  • Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma
    Sun R [2013]
  • Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong
    Ling W [2009]
  • Pretherapy quantitative measurement of circulating EpsteinBarr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type
    Leung SF [2003]
  • Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma
    Lee AW [2008]
  • Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma
    Leung SF [2006]
  • Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma
    Leung SF [2014]
  • Nasopharyngeal carcinoma treated by radical radiotherapy alone : Ten-year experience of a single institution
    Yi JL [2006]
  • Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma
    Lo YM [2000]
  • Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia : review
    Yu WM [2009]
  • Establishment of VCA and EBNA1 IgA-based combination by enzymelinked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma : a two-stage design with a preliminary performance study and a mass screening in southern China
    Liu Y [2012]
  • Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma
    Cai YL [2014]
  • Correlation analysis of nasopharyngeal carcinoma TNM staging with serum EA IgA and VCA IgA in EBV and VEGF-C and-D
    Sun R [2015]
  • Comparison of plasma Epstein-Barr virus(EBV)DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma
    Shao JY [2004]
  • Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma : a cohort study
    Du YY [2019]
  • Biomarker discovery of nasopharyngeal carcinoma by proteomics
    Xiao L [2014]
  • An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation
    Xu FH [2012]